Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.29
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.03
Today|||52-Week Range
0.35
+32.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$12.8M

Company Description

Enzon Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in the provision of licensing arrangements. It also involve in selling marketed drug products namely: PegIntron, Sylatron, Macugen, and CIMZIA. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

Contact Information

Enzon Pharmaceuticals, Inc.
20 Commerce Drive
Cranford New Jersey 07016
P:(732) 980-4500
Investor Relations:

Employees

Shareholders

Individual stakeholders24.73%
Mutual fund holders1.37%
Other institutional-1.27%

Top Executives

Andrew D. RackearChief Executive Officer & Secretary
Richard L. FeinsteinChief Financial & Accounting Officer, VP-Finance